CD9 and neoplasm: Moreover, RMS cases were also CD45−, CD56+lo, CD90+ and CD57−; two expressed CD81+, CD9+ and CD58+ and one was partially positive for CD99 (40% of tumor cells ), a phenotypic pattern which was specific for this tumor subtype (Table 2; Figures 1 and 2).